Questionnaire for data collection
Person in charge of human xenotransplantation practice.
Title : Mr.
First Name: Grant
Last name : Andrea
Address :
Zip :
State :
Country :
Institution : LCT
Telephone : +64 9 270 7941
Email : agrant@lctglobal.com
What is the source of your information about human xenotransplantation practices?
Congress
What is the therapeutic purpose of this xenotransplantation treatment?
Parkinson disease
Where and when is this human xenotransplantation practice taking place?
Country New Zealand
Timing in progress
Is this treatment part of a clinical trial?
Yes
How many patients are included in this clinical trial?
4
What are the inclusion criteria for patient selection?
i. Duration on the waiting list?
ii. Life-threatening diseases without alternative therapy? No
iii. Is a protocol available? No
If yes, could you please send a copy?
What is the animal source of the xenotransplantation product?
Pig
Source animals Do you have information about source animals? No
Testing of safety : Do you have information about testing of safety? No
What type of cells/tissues/organs was transplanted?
Cells:
Tissues:
Organs:
Others:
Choroid plexus
What type of exposure to xenogeneic cells was involved?
Solid-organ xenotransplantation: No
Cellular xenotransplantation: Yes
Tissue xenotransplantation: No
Human cells exposed to xenogeneic Feeder cell: No
Extracorporeal perfusion: No
Encapsulation: No
Other bioartificial isolation device:
Others:
Transplant Do you have information about transplant recipients? No
Have results been presented at a scientific congress?
Yes
if yes, where?
The joint congress of IXA and organ transplantation in ABO-incompatible and hyperimmunized recipient, 2013, Osaka, Japan
Have results been published in a scientific journal?
No
if yes, where?
Is this human clinical trial performed with governmental and/or institutional oversight and supervision?
No
if yes, which?
Comment

Internet: http://www.lctglobal.com/html/blob.php/1280877.pdf?attach=0&documentCode=5188&elementId=20084